GlassScriptPhysician profile
Taylor Robinson
NPI 1083270995
$1,930.61
in general payments reported to CMS, 2019-2025
11 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $112 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202 · Travel and Lodging: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.38 |
| Travel and Lodging | $728.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,207.10 | 2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.64 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $109.06 | 2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $100.24 | 2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $91.71 | 2025 | |
| Amgen INC. | $84.17 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $42.08 | 2024 | |
| Abiomed | $34.01 | 2025 | |
| Esperion Therapeutics, INC. | $28.94 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $21.33 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $16.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.